BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$856M |
| 2 |
NVIDIA
NVDA
|
+$816M |
| 3 |
Visa
V
|
+$762M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$717M |
| 5 |
Amazon
AMZN
|
+$513M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$427M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$305M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$214M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$199M |
| 5 |
Bank of America
BAC
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 7.59% |
| 3 | Financials | 7.37% |
| 4 | Healthcare | 7.24% |
| 5 | Communication Services | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
TFS Financial
TFSL
$4.93B
| $11.6K | ﹤0.01% |
921
-1,407
| -60% | -$17.7K |
|
|
SCPH
3552
DELISTED
scPharmaceuticals
SCPH
| $11.5K | ﹤0.01% |
2,652
-11,734
| -82% | -$51.6K |
|
3553
iShares Russell 1000 Value ETF
IWD
$84.3B
| $11.3K | ﹤0.01% |
65
-510,363
| -100% | -$89.2M |
|
3554
Universal Electronics
UEIC
$66.6M
| $11.2K | ﹤0.01% |
966
| – | – |
|
3555
Purple Innovation
PRPL
$28.7M
| $10.6K | ﹤0.01% |
408
-667
| -62% | -$23.5K |
|
3556
Adecoagro
AGRO
$1.31B
| $10.6K | ﹤0.01% |
1,090
| – | – |
|
3557
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$458M
| $10.5K | ﹤0.01% |
388
-130
| -25% | -$3.46K |
|
3558
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.24B
| $10.5K | ﹤0.01% |
244
+211
| +639% | +$9.05K |
|
3559
Puma Biotechnology
PBYI
$450M
| $10.5K | ﹤0.01% |
3,220
+2,978
| +1,231% | +$13.1K |
|
3560
Comtech Telecommunications
CMTL
$52.7M
| $10.3K | ﹤0.01% |
3,411
-10,075
| -75% | -$23.9K |
|
|
ADVM
3561
DELISTED
Adverum Biotechnologies
ADVM
| $10.3K | ﹤0.01% |
+1,497
| New | +$13.9K |
|
3562
Lifecore Biomedical
LFCR
$179M
| $10.2K | ﹤0.01% |
1,985
+1,293
| +187% | +$7.66K |
|
3563
GigaMedia
GIGM
$16.7M
| $10.1K | ﹤0.01% |
7,800
+200
| +3% | +$266 |
|
|
SVM
3564
Silvercorp Metals
SVM
$2.61B
| $10.1K | ﹤0.01% |
+3,009
| New | +$10.9K |
|
|
NAGE
3565
Niagen Bioscience
NAGE
$241M
| $10.1K | ﹤0.01% |
3,690
+3,523
| +2,110% | +$11.8K |
|
|
CANG
3566
Cango Inc
CANG
$92.7M
| $10K | ﹤0.01% |
600
+80
| +15% | +$1.23K |
|
3567
Corporacion America
CAAP
$6.42B
| $9.97K | ﹤0.01% |
599
-12,697
| -95% | -$221K |
|
3568
X4 Pharmaceuticals
XFOR
$425M
| $9.91K | ﹤0.01% |
570
-1,483
| -72% | -$48.5K |
|
|
AEVA
3569
Aeva Technologies
AEVA
$1.56B
| $9.63K | ﹤0.01% |
3,820
-4,049
| -51% | -$13.2K |
|
3570
Kyverna Therapeutics
KYTX
$500M
| $9K | ﹤0.01% |
+1,200
| New | +$18.3K |
|
3571
FibroBiologics
FBLG
$7.66M
| $8.98K | ﹤0.01% |
+90
| New | +$17.2K |
|
3572
iShares Core S&P US Value ETF
IUSV
$28B
| $8.81K | ﹤0.01% |
100
+66
| +194% | +$5.82K |
|
|
CTNM
3573
Contineum Therapeutics
CTNM
$576M
| $8.8K | ﹤0.01% |
+500
| New | +$8.05K |
|
|
AIFU
3574
AIFU Inc
AIFU
$218M
| $8.76K | ﹤0.01% |
11
+9
| +450% | +$12.1K |
|
3575
NLI Holdings
NL
$319M
| $8.72K | ﹤0.01% |
1,447
-2,482
| -63% | -$18.5K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2024 Portfolio in Review
As of Q2 2024, BNP Paribas Financial Markets held 4,270 positions worth $123B, up 7.8% from $114B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $7.82B of net new capital in Q2 2024, opening 230 new positions and adding to 1,339 existing holdings. Its largest new stake was Flutter Entertainment: 782,106 shares worth $143M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $427M trimmed.
- BNP Paribas Financial Markets's largest Q2 2024 buy was Flutter Entertainment: 782,106 shares worth $143M.
- BNP Paribas Financial Markets added most to Microsoft in Q2 2024, an estimated $856M increase.
- BNP Paribas Financial Markets's biggest Q2 2024 reduction was Apple, cutting an estimated $427M.
- BNP Paribas Financial Markets fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $214M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $123B portfolio in Q2 2024.
- BNP Paribas Financial Markets opened 230 new positions and closed 234 in Q2 2024.
- BNP Paribas Financial Markets's portfolio value rose 7.8% quarter-over-quarter to $123B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2024, filed 13 Aug 2024.